CVS Health Settles $315M Opioid Prescription Claims
FROM THE WIRE · GURUFOCUS.COM
On October 13, 2026, CVS Health Corp (NYSE: CVS) announced a $315 million settlement to resolve allegations related to improper opioid and controlled substance
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe $315 million settlement represents a legal closure for CVS with moderate impact on financial results.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01CVS Health announced a $315 million settlement on October 13, 2026.
- 02The settlement resolves allegations related to improper opioid and controlled substance prescriptions.
- 03The payment represents a legal closure for the healthcare company.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets